Himalaya Nutravedics IPO Day 3: Subscription Closes Today, 24 September 2026

Himalaya Nutravedics IPO closes today, 24 Sep 2026. Subscribed 0.40x through Day 2 (5:06 PM): Retail 0.67x, NII 0.32x, QIB 0.00x. Price band Rs 100-106.

Updated: 24 Sept 2026 • 1:02 am

Posted by:

Quick Answer

The Himalaya Nutravedics IPO is on its final day of bidding on 24 September 2026, with the subscription window closing today. The issue has built through its bidding window, from 0.11 times at the Day 1 close to around 0.40 times by the close of Day 2, with retail leading at 0.67 times, NII at 0.32 times, and QIB, excluding anchors, yet to receive bids. With bidding open until the end of today's session, the final Himalaya Nutravedics IPO subscription figure depends on how much demand arrives across categories in the closing hours.

Himalaya Nutravedics India Limited, an Ayurvedic and nutraceutical formulations manufacturer, has reached the final day of its IPO subscription window today, 24 September 2026. The Himalaya Nutravedics IPO opened on 22 September and is a book built SME issue worth about Rs 26.50 crore, entirely a fresh issue. The shares are proposed to list on the BSE SME platform.

Demand for the issue has improved steadily through the bidding window, moving from 0.11 times through Day 1 to around 0.40 times by the close of Day 2, led by retail investors. The QIB category, excluding anchors, has yet to show activity, and today's closing session is the last opportunity for the book to move meaningfully closer to full subscription.

Click Here – Get Free Investment Predictions

Table of Contents

Himalaya Nutravedics IPO Details

The table below sets out the key parameters of the issue.

Open Date	22 September 2026
Close Date	24 September 2026
Price Band	Rs 100 to Rs 106 per share
Lot Size	1,200 shares
Issue Size	Rs 26.50 crore (entirely fresh issue)
Issue Type	Book Built Issue, SME
Listing At	BSE SME
Allotment Date	25 September 2026
Listing Date	29 September 2026

Himalaya Nutravedics IPO Subscription Status Day 3

The table below tracks how the issue has moved through its bidding window, from the Day 1 close through to the close of Day 2.

Session	Overall	Retail	NII	QIB
Day 1 close (22 Sep, 5:04 PM)	0.11x	0.16x	0.14x	N/A
Day 2 close (23 Sep, 5:06 PM)	0.40x	0.67x	0.32x	0.00x
Day 3, closing day so far (24 Sep)	Updating through the session

Retail investors have led the issue through the bidding window, with NII also building steadily, while the QIB book, excluding anchors, has yet to open up. Investors should check the live BSE numbers as today's final session progresses.

Track Subscription Status for the issue on the Univest Screener

How to Apply for the Himalaya Nutravedics IPO

Open a Demat and trading account with a SEBI-registered broker such as Univest if you do not already have one.
Select the issue on your broker app or net banking platform and enter your bid quantity and price within the Rs 100 to Rs 106 band, with a minimum bid of 2,400 shares.
Submit the application through the UPI-based ASBA method so the bid amount is blocked rather than debited immediately.
Approve the UPI mandate on your phone well before the cut off today, since the issue closes for good after this session.

Download the Univest iOS App or Univest Android App to apply for the issue before it closes today.

Grey market premium (GMP) is an unofficial, unregulated indicator for the Himalaya Nutravedics India IPO that is not endorsed by SEBI, NSE, or BSE. Investors looking for indicative GMP data can go through other relevant sources, though such figures should never be the sole basis for an investment decision.

Conclusion

The issue closes today with subscription still below full book at around 0.40 times through Day 2, led by retail demand while QIB has room to build in the final hours. Investors considering the issue should review the company financials and SME liquidity risks in the RHP on bseindia.com, and apply only after independent due diligence before the window shuts today.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs

What is the Himalaya Nutravedics IPO subscription status on Day 3?

Ans. On the closing day, 24 September 2026, the issue carries forward a Day 2 close of around 0.40 times overall, with retail at 0.67 times, NII at 0.32 times, and QIB at 0.00 times, and figures are updating through today's final session.

When does the Himalaya Nutravedics IPO close?

Ans. The issue closes for subscription today, 24 September 2026, having opened on 22 September 2026.

What is the Himalaya Nutravedics IPO price band and lot size?

Ans. The issue price band is Rs 100 to Rs 106 per share, with a lot size of 1,200 shares, taking the minimum investment to about Rs 2,54,400 for two lots.

Which category led the Himalaya Nutravedics IPO subscription?

Ans. Retail investors led the issue through Day 2, reaching 0.67 times, ahead of NII at 0.32 times, while the QIB category, excluding anchors, had not received any bids.

What is the Himalaya Nutravedics IPO GMP?

Ans. Grey market premium (GMP) is an unofficial, unregulated indicator for the issue that is not endorsed by SEBI, NSE, or BSE. Investors looking for indicative GMP data can go through other relevant sources, though such figures should never be the sole basis for an investment decision.

How do I apply for the Himalaya Nutravedics IPO before it closes?

Ans. You can apply for the issue through your SEBI-registered broker or UPI-enabled banking app using the ASBA method, entering your bid with a minimum of 2,400 shares within the Rs 100 to Rs 106 band and approving the UPI mandate before today's cut off.

When will the Himalaya Nutravedics IPO be allotted and listed?

Ans. The issue allotment is expected to be finalised on 25 September 2026, with listing on the BSE SME platform tentatively scheduled for 29 September 2026.

Is the Himalaya Nutravedics IPO likely to close fully subscribed?

Ans. With the issue running at around 0.40 times through Day 2 and QIB yet to open, the issue would need a strong final session across all categories to cross full subscription, and the outcome should be confirmed on BSE once bidding closes today.

What is the reservation split in the Himalaya Nutravedics IPO?

Ans. The issue reserves around 50 percent of the offer for qualified institutional buyers, about 35 percent for retail individual investors, and roughly 15 percent for non-institutional investors.

What does Himalaya Nutravedics India Limited do?

Ans. Himalaya Nutravedics India Limited manufactures, markets and distributes Ayurvedic and nutraceutical formulations, including classical Shastric formulations and proprietary products, and also undertakes third-party contract manufacturing.